Hyderabad-based Indian Immunologicals Limited (IIL) has partnered with Australia’s Griffith University to develop the COVID-19 vaccine. Scientists from IIL and Griffith University will jointly develop a “live attenuated SARS – CoV-2 vaccine” or COVID-19 vaccine using the “latest codon de-optimization technology”.
Click Here To Get Test Series For SBI PO 2020
The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization. Upon the completion of the research, the vaccine strain will be transferred to ILL. It will work with the Central Drugs Standard Control Organisation (CDSCO), to conduct clinical trials. IIL intends to use its Vero cell platform tech for mass production of the vaccine.
What is Indian Immunologicals Limited?
Indian Immunologicals Limited is a major player in the human vaccine market in the country, supplying human pediatric and rabies vaccines. IIL is also a major supplier of pediatric vaccines to the country’s state-run universal immunization programme. IIL is promoted by the National Dairy Development Board. It is committed to addressing critical public health needs by engaging in this collaboration.
Important takeaways for all competitive exams:
The Gujarat High Court has issued the policy which the banning the use of Artificial…
The census is an important process through which a country collects information about its population.…
India has launched Sadhana Saptah 2026 which is the nationwide initiative which is focused on…
Rating agency Moody has lowered the India's economic growth for the FY27. Moody's have projected…
Our Earth has seven continents and each one is different in its land, weather and…
Income Tax Department of India has launched a new platform called 'Kar Saathi'. It is…